PTX3 and pancreatic adenocarcinoma: Kamal et al. detected high levels of PTX-3 in early stages of pancreatic adenocarcinoma for 200 patients and also obtained good sensitivity and specificity values (0.63 and 0.85, respectively) for PTX-3 in proteomics analysis, suggesting therefore the quantification of serum PTX-3 as a reliable diagnostic biomarker [120].